chlortetracycline
Commercial- Indications
- Bacterial infections
Company intelligence / Profile preview
Historically developed and commercialized a wide range of chemical, pharmaceutical, agricultural, and consumer products. Notable for early antibiotic development through its Lederle division. No current clinical results as the company was acquired in the mid–1990s.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American Cyanamid.